Swissmedic
First malaria medicine for infants under 4.5kg receives approval
July 9, 2025Medical Communications, Research and Development Coartem Baby, Infections and infestations, Medicines for Malaria Venture, Novartis, Paediatrics, Swissmedic, malaria
Coartem (artemether-lumefantrine) Baby, or Riamet, has been approved by Swissmedic as the first malaria medicine for newborns and young infants. …
Relief Therapeutics awarded approval from Swissmedic for new GMP-compliant laboratory
May 15, 2023Research and Development GMP, Relief Therapeutics, Swissmedic, laboratory
Swiss biopharmaceutical company Relief Therapeutics has announced that its state-of-the-art R&D laboratory in Balerna, Switzerland, has been audited and approved …
Regulators ‘more efficient at approving drugs’
January 19, 2015Research and Development, Sales and Marketing EMA, EMA), FDA, Health Canada, PMDA)., Pharmaceutical and Medical Devices Agency, Swissmedic, TGA, approvals, cirs, reuters
Global regulatory bodies have become faster at approving new drug products more quickly and consistently, according to a new analysis …
